Fortress Biotech, Inc. (FBIO)
2.03
-0.04
(-1.93%)
USD |
NASDAQ |
Oct 02, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Price : 2.03 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 2.08 | 2.09 | 2.01 | 2.03 | 327172.0 |
| Oct 01, 2026 | 2.17 | 2.17 | 2.07 | 2.07 | 286249.0 |
| Sep 30, 2026 | 2.20 | 2.20 | 2.14 | 2.14 | 221331.0 |
| Sep 29, 2026 | 2.20 | 2.21 | 2.14 | 2.20 | 257166.0 |
| Sep 28, 2026 | 2.26 | 2.270 | 2.17 | 2.17 | 263259.0 |
| Sep 25, 2026 | 2.27 | 2.32 | 2.26 | 2.28 | 264894.0 |
| Sep 24, 2026 | 2.33 | 2.345 | 2.28 | 2.28 | 203678.0 |
| Sep 23, 2026 | 2.445 | 2.445 | 2.33 | 2.34 | 331816.0 |
| Sep 22, 2026 | 2.42 | 2.47 | 2.40 | 2.45 | 199727.0 |
| Sep 21, 2026 | 2.50 | 2.52 | 2.39 | 2.41 | 283345.0 |
| Sep 18, 2026 | 2.50 | 2.565 | 2.47 | 2.51 | 414781.0 |
| Sep 17, 2026 | 2.49 | 2.51 | 2.44 | 2.51 | 167536.0 |
| Sep 16, 2026 | 2.48 | 2.505 | 2.41 | 2.46 | 352886.0 |
| Sep 15, 2026 | 2.51 | 2.530 | 2.46 | 2.49 | 225324.0 |
| Sep 14, 2026 | 2.50 | 2.54 | 2.46 | 2.53 | 226477.0 |
| Sep 11, 2026 | 2.59 | 2.625 | 2.52 | 2.52 | 209700.0 |
| Sep 10, 2026 | 2.60 | 2.625 | 2.53 | 2.57 | 315547.0 |
| Sep 09, 2026 | 2.67 | 2.70 | 2.62 | 2.63 | 280402.0 |
| Sep 08, 2026 | 2.69 | 2.75 | 2.67 | 2.71 | 263047.0 |
| Sep 04, 2026 | 2.68 | 2.74 | 2.675 | 2.72 | 168144.0 |
| Sep 03, 2026 | 2.75 | 2.76 | 2.695 | 2.71 | 148110.0 |
| Sep 02, 2026 | 2.67 | 2.74 | 2.67 | 2.73 | 279774.0 |
| Sep 01, 2026 | 2.69 | 2.77 | 2.63 | 2.68 | 605781.0 |
| Aug 31, 2026 | 2.795 | 2.795 | 2.69 | 2.735 | 326338.0 |
| Aug 28, 2026 | 2.80 | 2.81 | 2.745 | 2.77 | 309687.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Inovio Pharmaceuticals, Inc. | 1.16 |
| Kura Oncology, Inc. | 10.65 |
| Spero Therapeutics, Inc. | 1.19 |
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
Price Related Metrics
| PE Ratio | 0.7641 |
| PS Ratio | 0.9982 |
| Price to Book Value | 0.412 |
| Price to Free Cash Flow | 0.5682 |
| Earnings Yield | 130.9% |
| Market Cap | 67.62M |
| Normalized PE Ratio | 0.829 |